共 226 条
[1]
Effah CY(2020): an increasing threat to public health Ann Clin Microbiol Antimicrob 19 1-281
[2]
Sun T(2020)Nano-based drug delivery or targeting to eradicate bacteria for infection mitigation: a review of recent advances Front Chem 8 286-1274
[3]
Liu S(2018)Nano based drug delivery systems: recent developments and future prospects J Nanobiotechnol 16 71-19
[4]
Wu Y(2019)Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery Pharmaceutics 11 55-1212
[5]
Yeh YC(2012)Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance Clin Microbiol Infect 18 268-619
[6]
Huang TH(2014)Vancomycin-eluting niosomes: a new approach to the inhibition of staphylococcal biofilm on abiotic surfaces AAPS PharmSciTech 15 1263-059
[7]
Yang SC(2006)Niosomes as carriers for tretinoin. III A study into the Int J Pharm 311 11-1106.e8
[8]
Chen CC(2000) cutaneous delivery of vesicle-incorporated tretinoin Am J Respir Crit Care Med 161 1206-1022
[9]
Fang JY(2004)Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with J Antimicrob Chemother 53 616-30
[10]
Patra JK(2003)Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria Blood Press 140 79-290